Rajesh Shrotriya
Director/Board Member at GT BIOPHARMA, INC.
Net worth: - $ as of 2024-03-30
Profile
Rajesh C.
Shrotriya is an Independent Director at GT Biopharma, Inc. and a Director at Allos Therapeutics, Inc. He is also a former Chairman & Chief Executive Officer at Spectrum Pharmaceuticals, Inc. and a former Executive Director-Worldwide CNS Clinical Research at Bristol Myers Squibb Co. Additionally, he served as a Director at CASI Pharmaceuticals, Inc., Antares Pharma, Inc., and Theralink Technologies, Inc. (Colorado).
He was also the Chief Medical Officer & VP-Medical Affairs at MGI PHARMA, Inc. and the Chief Scientific Officer & Executive VP at SuperGen, Inc. Dr. Shrotriya received his undergraduate degree from Dr. Bhim Rao Ambedkar University in 1962, his undergraduate degree from Armed Forces Medical College in 1967, and his doctorate degree from The Grant Government Medical College in 1974.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GT BIOPHARMA INC
-.--% | 2023-10-22 | 0 ( -.--% ) | - $ | 2024-03-30 |
Rajesh Shrotriya active positions
| Companies | Position | Start |
|---|---|---|
| GT BIOPHARMA, INC. | Director/Board Member | 2021-01-12 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Director/Board Member | 2012-09-04 |
The UNLV Foundation
 The UNLV Foundation Investment Trusts/Mutual FundsMiscellaneous The UNLV Foundation provides financial services. The non-profit company is based in Las Vegas, NV and has subsidiaries in United States. | Director/Board Member | - |
Shrotriya Family Foundation
 Shrotriya Family Foundation Investment Trusts/Mutual FundsMiscellaneous Shrotriya Family Foundation operates as a grant making foundation. The private company is based in Henderson. | Director/Board Member | - |
| Cs Family Trust | Director/Board Member | - |
| Spectrum Pharmaceuticals Cayman LP | Director/Board Member | - |
Former positions of Rajesh Shrotriya
| Companies | Position | End |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Chief Executive Officer | 2017-12-16 |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Chief Tech/Sci/R&D Officer | 2000-07-31 |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Chief Tech/Sci/R&D Officer | 1996-09-30 |
| ░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Rajesh Shrotriya
| Dr. Bhim Rao Ambedkar University | Undergraduate Degree |
| Armed Forces Medical College | Undergraduate Degree |
| The Grant Government Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| GT BIOPHARMA, INC. | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 10 |
|---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
| Spectrum Pharmaceuticals Cayman LP | |
The UNLV Foundation
The UNLV Foundation Investment Trusts/Mutual FundsMiscellaneous The UNLV Foundation provides financial services. The non-profit company is based in Las Vegas, NV and has subsidiaries in United States. | Miscellaneous |
Shrotriya Family Foundation
Shrotriya Family Foundation Investment Trusts/Mutual FundsMiscellaneous Shrotriya Family Foundation operates as a grant making foundation. The private company is based in Henderson. | Miscellaneous |
| Cs Family Trust | Miscellaneous |
Theralink Technologies, Inc. (Colorado)
 Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
- Stock Market
- Insiders
- Rajesh Shrotriya
